首页> 外文期刊>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery >Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency.
【24h】

Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency.

机译:导管定向溶栓治疗durable股深静脉血栓形成是持久的,可保留静脉瓣膜功能,并可预防慢性静脉功能不全。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To investigate the results of catheter directed thrombolysis offered to patients with acute femoro-iliac deep venous thrombosis (DVT). DESIGN: Retrospective analysis of all patients treated with this modality at Gentofte Hospital until December 2003. MATERIAL: Forty-five consecutive patients treated between June 1999 and December 2003 with a median age of 31 years. All patients had femoro-iliac DVT with an average anamnesis of 6 days. METHODS: All patients were treated by catheter directed infusion of alteplase into the popliteal vein. After thrombolysis residual venous stenoses were treated by percutaneous balloon angioplasty (PTA) and stenting. Patients were followed with color-duplex scanning for assessment of venous patency and reflux. RESULTS: Forty-two of 45 (93%) of cases were treated successfully with reopening of the thrombosed vein segments. In 30 of 45 cases a residual stenosis was treated by PTA and stenting. Only one serious complication was observed: Compartment syndrome of the forearm where arterial punctures had been taken. After an average of 24 months follow-up were no cases of re-thrombosis among the 42 patients discharged with open veins. Only two of 41 with presumed normal venous valve function prior to DVT developed reflux during follow-up. CONCLUSION: In this selected patient group, catheter directed thrombolysis seems effective in treating acute DVT, it appears durable and preserves venous valve function in the majority. The method needs to be tested in a randomised controlled trial.
机译:目的:调查为急性股-深静脉血栓形成(DVT)患者提供的导管定向溶栓治疗的结果。设计:回顾性分析Gentofte医院直至2003年12月的所有接受这种方式治疗的患者。材料:1999年6月至2003年12月之间接受治疗的45例患者,中位年龄为31岁。所有患者均患有股-DVT,平均复查时间为6天。方法:所有患者均接受导管定向输注阿替普酶至the静脉。溶栓后,通过经皮球囊血管成形术(PTA)和支架置入术治疗残留的静脉狭窄。对患者进行彩色双工扫描以评估静脉通畅性和反流。结果:45例病例中有42例(93%)通过重新开放血栓形成的静脉段成功治疗。 45例中有30例通过PTA和支架置入术治疗残余狭窄。仅观察到一种严重的并发症:曾进行动脉穿刺的前臂隔室综合征。在平均24个月的随访之后,在42例开放静脉出院的患者中没有再形成血栓的病例。在DVT之前,假定静脉瓣功能正常的41名患者中只有2名在随访期间出现反流。结论:在这个选定的患者组中,导管定向溶栓治疗似乎可有效治疗急性DVT,它看起来持久并且在大多数患者中保留了静脉瓣膜功能。该方法需要在随机对照试验中进行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号